Introduction
============

Antimicrobial resistance is becoming a great challenge to public health worldwide ([@B13]). The rapid evolution of MDR Gram-negative bacteria is pushing humankind to the cusp of a post-antibiotic era. Colistin (polymyxins E) is a family of cationic polypeptide antibiotics which acts as the last line of defense in the treatment of severe bacterial infections by MDR or XDR bacteria. In particular, colistin is used to treat ESBL-producing and CRE infections ([@B15]; [@B24]).

Colistin resistance was assumed to be chromosomally mediated, non-transmissible and an intrinsic property of the bacteria ([@B22]). However, the recent discovery of the *Escherichia coli* harboring plasmid-borne colistin resistance gene *mcr-1* confirms transmission of colistin resistance by HGT ([@B17]). The MCR-1 encodes a PEA transferase that adds PEA to the lipid A of the lipopolysaccharide, leading to Gram-negative bacteria resistant to colistin ([@B1]). This HGT mechanism of colistin resistance has alarmed the medical, media, academic and public health communities.

The global spread of the *mcr-1* gene is now evident and being documented. Currently, researchers have discovered five *mcr*-like genes, ranging from *mcr-1* to *mcr-5*, with a series of *mcr* genetic variants such as *mcr-1.2, mcr-1.3* ...*mcr-1.12.* These *mcr* genes have spread to 40 countries across 5 of 7 continents in multiple ecosystems, including the environment, food, animals (e.g., pig, poultry, and cattle) and humans, and in over 11 species of Enterobacteriaceae ([@B26]; [@B5]; [@B6]). Retrospective studies have shown that an isolate harboring the *mcr-1* gene had already existed in three chicken *E. coli* isolates in China from the 1980s ([@B27]). The presence of *mcr-1* in livestock is indicative of the route of *mcr-1* dissemination through the food chain and it is gravely concerning that animal-to-human transmission of MCR-1 colistin resistance has already been found in many countries.

Mobile genetic elements such as conjugative plasmids, transposons, integrons and IS are important vehicles of HGT of the *mcr-1* gene ([@B9]; [@B33]). Conjugative plasmids are the main driving force for the dissemination of the *mcr-1* gene, and the plasmids IncI2 and IncX4 are the two leading plasmid types for facilitating the global dissemination of colistin resistance ([@B20]; [@B41]). The *mcr-1* gene is part of an approximately 2.6-kb *mcr-1-pap2* element that contains the likely promoter regions for *mcr-1* transcription ([@B25]; [@B41]). There are also rare cases involving chromosomally integrated *mcr-1*genes ([@B37]; [@B34]), which are indicative of non-lineage-specific vertical dissemination of *mcr-1.*

Detection of *mcr* genes helps in the tracking, slowing, and responding to the emergence of antibiotic resistance in Chinese livestock farming. At the end of 2015, the *mcr-1-*harboring *E. coli* strain SHP45 was isolated from pigs in Shanghai ([@B17]). Also, in 2016, the colistin-resistant *E. coli* EC11 strain was isolated from cow feces collected from a commercial dairy farm. We will use WGS to outline the mechanism for acquiring and transferring colistin resistance in this strain.

Materials and Methods {#s1}
=====================

Bacterial Strains and Identification
------------------------------------

In May 2016, we cultured *E. coli* strains from fecal samples collected from a commercial dairy farm in Shanghai, China. Samples (25 g) were dispensed in sterile plastic bags containing 225 ml of Mueller--Hinton broth and incubated at 37°C for 24 h. All samples were seeded on MacConkey agar plates with 2 μg/mL colistin and incubated at 37°C for 18 h. One putative positive *E. coli* colony per sample was selected on the basis of morphology, size, and color (peachblow), then inoculated overnight on eosin-methylene blue agar. Species were further confirmed by the amplification and sequencing of 16S rRNA, while SEM and TEM image analyses were conducted. All bacterial isolates were stored in the Luria-Bertani medium (Land Bridge, Beijing, China) with 30% glycerol at -80°C.

*mcr-1* and β-Lactamase Gene Screening
--------------------------------------

Screening for the *mcr-1* gene was performed using PCR amplification and sequencing. The specific primers used to produce the 309 bp amplicon were as previously described: CLR5-F (5′-CGGTCAGTCCGTTTGTTC-3′) and CLR5-R (5′-CTTGGTCGGTCTGTAGGG-3′) ([@B17]). Further screening for the presence of the *mcr-2, mcr-3* and the main β-lactamase gene groups (*bla*~TEM~, *bla*~SHV~, *bla*~CTX-M~, *bla*~KPC~, and *bla*~NDM~) was performed by previously reported primers. In this study, all primers used are presented in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. Each PCR reaction system was performed in 25 μL, containing 12.5 μL of PCR Mix (Sangon Biotech, Shanghai, China), 9.5 μL of dd H~2~O, 1 μL of forward and reverse primers, and 1 μL of DNA template. Finally, one *E. coli* isolate designated as *E. coli* EC11 was determined to harbor the *mcr-1* gene, and this isolate was selected to perform the follow-up experiments.

Antibiotic Susceptibility Testing
---------------------------------

The MIC for 22 common antibiotics was determined for the isolate of *E. coli* EC11 by the broth dilution method on Mueller--Hinton broth (Oxoid, United Kingdom) following incubation at 37°C for 18--24 h. In this study, the 22 tested antibiotics we used are categorized into seven groups as shown in Table [1](#T1){ref-type="table"}. The results were interpreted according to CLSI document M100-S25 (2015)^[1](#fn01){ref-type="fn"}^ except for tigecycline and colistin, which were interpreted by the EUCAST (version 6.0)^[2](#fn02){ref-type="fn"}^ guidelines. The double disk test (ceftazidime + ceftazidime/clavulanic acid and cefotaxime + cefotaxime/clavulanic acid) was performed to confirm the ESBL phenotype, and *E. coli* ATCC 25922 was used as a quality control.

###### 

Minimum inhibitory concentration (μg/mL) for *Escherichia coli* EC11, transconjugant EC11-T and recipient *E. coli* C600.

  Type of antibiotic     Antibiotic                      MIC (μg/mL)^∗^                
  ---------------------- ------------------------------- ---------------- ------------ ------------
  β-lactams              Amoxicillin-clavulanic          2(S)             2(S)         2(S)
                         Ampicillin                      4(S)             8(S)         8(S)
                         Piperacillin                    2(S)             4(S)         4(S)
                         Cefotaxime                      \<0.125(S)       0.25(S)      0.25(S)
                         Ceftazidime                     0.25(S)          0.5(S)       1(S)
                         Cefoxitin                       8(S)             4(S)         4(S)
                         Cephazolin                      2(S)             4(S)         4(S)
                         Cefepime                        \<0.125(S)       0.25(S)      \<0.125(S)
                         Imipenem                        0.5(S)           1(S)         0.5(S)
                         Meropenem                       \<0.125(S)       \<0.125(S)   \<0.125(S)
  Aminoglycoside         Amikacin                        4(S)             4(S)         8(S)
                         Gentamicin                      2(S)             1(S)         1(S)
                         Kanamycin                       4(S)             4(S)         4(S)
  Tetracycline           Tetracycline                    1(S)             1(S)         1(S)
                         Tigecycline                     \<0.125(S)       \<0.125(S)   \<0.125(S)
  Quinolone              Ciprofloxacin                   \<0.125(S)       0.125(S)     \<0.125(S)
                         Levofloxacin                    \<0.125(S)       0.25(S)      0.5(S)
                         Nalidixic acid                  4(S)             \>128(R)     \>128(R)
  Amino alcohol          Chloramphenicol                 16(S)            8(S)         8(S)
  Sulfonamide            Trimethoprim-sulfamethoxazole   8(R)             8(R)         8(R)
  Cationic polypeptide   Polymyxin B                     4(R)             4(R)         1(S)
                         Colistin                        8(R)             4(R)         1(S)

MIC, minimum inhibitory concentration; R, resistant; I, intermediate; S, susceptible.

∗

In vitro antimicrobial susceptibility was performed by broth microdilution method and the MICs were interpreted according to Clinical and Laboratory Standards Institute (CLSI) criteria, except for tigecycline, colistin and polymyxin B, which interpretation were performed according to the EUCAST guidelines

.

Conjugation Assay
-----------------

To determine whether the colistin resistance was carried on a transferable plasmid, a conjugation experiment by filter mating assay ([@B28]) was performed with rifampicin-resistant *E. coli* C600 as the recipient strain. Overnight cultures of the original isolates and recipient *E. coli* C600 in LB broth were adjusted to a 0.5 McFarland standard. A 10 μl aliquot of each culture was individually added to 2 ml of fresh LB broth and then incubated at 37°C for 6 h. The original strains (20 μl) were then separately conjugated with *E. coli* C600 (60 μl) on a microporous membrane. Transconjugants were selected on MacConkey agar plates supplemented with colistin (2 μg/mL) and rifampicin (40 μg/mL), and putative transconjugants were confirmed by both PCR and an antimicrobial susceptibility test (above 22 antibiotics). The mobilization efficiency was calculated as the number of transconjugant colonies divided by the number of donor colonies ([@B39]).

Multilocus Sequence Typing
--------------------------

The clonal lineage of the *E. coli* EC11 strain was studied using MLST. MLST was performed as previously described ([@B35]). The seven conserved housekeeping genes (*adk, fum*C, *gyr*B, *icd, mdh, pur*A, and *rec*A) were chosen as targets^[3](#fn03){ref-type="fn"}^ and PCR fragments were sequenced. The alignments of these sequences were determined using DNAMAN software. These sequences were then analyzed using the facility provided by the above-mentioned online tool to assign allele numbers and define the ST and CC.

Furthermore, in order to explore possible genetic relationships between *E. coli* EC11 and other *E. coli* isolates harboring *mcr* reported worldwide, we performed a systematic review of the literature on *mcr* published in the NCBI-Pubmed database between November 2015 and March 2018. A phylogenetic tree was constructed using a NJ method by MEGA5.0 software, where the phylogenetic relationships among different strains were analyzed based on nucleotide differences. In addition, we conducted cluster analysis of these strains to understand the relationship between the different ST groups. The eBURST algorithm was used to group strains according to their allelic profiles by employing a user-specified group definition as well as drawing a rough sketch^[4](#fn04){ref-type="fn"}^ to show the genetic relationship.

Whole Genome Sequencing
-----------------------

Genomic DNA of *E. coli* strain EC11 was extracted from an overnight culture using the TIANamp Bacteria DNA Kit (Tiangen Biotech Beijing Co., Ltd., China) according to manufacturer's instructions. WGS data were generated using short-read (Illumina, San Diego, CA, United States), producing 2 × 251-bp paired-end reads, and long-read (Pacific Biosciences, Menlo Park, CA, United States) technology. The raw data were assembled using SPAdesv3.9.0 ([@B2]). Gene prediction and annotation were done with Glimmer 3.02 and BLAST. All sequences were deposited under the Bioproject [PRJNA436212](PRJNA436212). Serotypes, plasmid replicons, and *E. coli* virulence genes were identified by using SerotypeFinder1.1, PlasmidFinder1.3, and VirulenceFinder1.5, respectively, available from the Center for Genomic Epidemiology^[5](#fn05){ref-type="fn"}^. Insertion sequence (IS) elements were identified using ISfinder^[6](#fn06){ref-type="fn"}^. Additional characterization of chromosomal resistance determinants was performed using the CARD Resistance Gene Identifier^[7](#fn07){ref-type="fn"}^, and ResFinder^[8](#fn08){ref-type="fn"}^ was used to detect acquired resistance genes commonly located on mobile genetic elements. The sequence comparison and map generation were performed using BLAST^[9](#fn09){ref-type="fn"}^ and Easyfig version 2.1 ([@B29]). Conjugal transfer components of the plasmids were performed using *oriT*finder ([@B16]).

Results
=======

Identification of *mcr-1*-Positive *E. coli* Isolates
-----------------------------------------------------

In our study, out of 120 *E. coli* isolates collected from dairy cow fecal samples in May 2016 in Shanghai, only the *E. coli* isolate EC11 (Supplementary Figures [S1](#SM1){ref-type="supplementary-material"}, [S2](#SM1){ref-type="supplementary-material"}) carried the *mcr-1*gene, and none of these isolates carried *mcr-2/3* determinants or the allelic variants.

Susceptibility to Antimicrobial and Conjugative Compounds
---------------------------------------------------------

According to EUCAST standards, the resistance cutoff of *E. coli* to colistin is 2 mg/L and the *E. coli* EC11 strain exhibited the lower level of colistin resistance (8 μg/mL) (Table [1](#T1){ref-type="table"}). *E. coli* EC11 also showed resistance to polymyxin B, and trimethoprim-sulfamethoxazole; but it was susceptible to other 19 common antibiotics, including amoxicillin-clavulanic, ampicillin, piperacillin, cefotaxime, ceftazidime, cefoxitin, cephazolin, cefepime, imipenem, meropenem, amikacin, gentamicin, kanamycin, tetracycline, tigecycline, ciprofloxacin, levofloxacin, nalidixic acid, chloramphenicol (Table [1](#T1){ref-type="table"}). PCR results showed that *E. coli* EC11 didn't carry the β-lactamase genes, including *bla*~TEM~, *bla*~SHV~, *bla*~CTX-M~, *bla*~KPC~, and *bla*~NDM~. Furthermore, the double disk test suggested that *E. coli* EC11 was a non-ESBL producing isolate (Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}).

In addition, the filter mating assays indicated that the *mcr-1*-carrying plasmid could be successfully transferred from the donor (*E. coli* EC11) to the recipient (*E. coli* C600) with an average efficiency of 4.6 × 10^-5^. The MIC value of the transconjugant EC11-T to colistin was 8 μg/mL, which showed an eightfold increase when compared with the recipient *E. coli* C600 (1 μg/mL). The transconjugant *E. coli* EC11-T was also found to have resistance to nalidixic acid, trimethoprim-sulfamethoxazole and polymyxin B.

A Diversity of the *mcr-1* Positive *E. coli* Isolates
------------------------------------------------------

Multilocus sequence typing (MLST) showed that *E. coli* EC11 belonged to the ST278 lineage. Based on the literature review, details of the *E. coli* strains harboring *mcr* genes, including the source and year of isolation, the presence of the MDR phenotype, ST, and allelic profile, are presented in Supplementary Table [S2](#SM2){ref-type="supplementary-material"}. A total of 245 STs were identified among the 616 *E. coli* isolates, indicating a high degree of genotypic diversity.

The application of eBURST resolved the 245 STs into 10 clonal complexes (CC10, CC206, CC46, CC1114, CC648, CC101, CC642, CC6866, CC55, and CC23). CC10 remained the most populated clonal complex and ST10 was defined as the ancestral type of CC10 (Figure [1](#F1){ref-type="fig"}). The geographical distribution of the different STs is shown in Supplementary Table [S3](#SM1){ref-type="supplementary-material"}. These ST types were distributed in more than 35 cities across six continents. ST10 was isolated on five continents and China was the country where the most *mcr*-positive *E. coli* strains were found, with as many as 162 different STs being discovered.

![The eBURST cluster analysis of the genetic relationships of the *mcr*-positive *Escherichia coli* strains. The analysis is based on allelic profiles of MLST data and displays clusters of linked and individual unrelated STs. The digital represents the ST type, each black node represents a sequence type, the blue nodes represent clonal ancestors, the yellow nodes represent clonal subpopulation ancestors, and the red circle represents the sequence type of *E. coli* EC11 in this study.](fmicb-09-02833-g001){#F1}

A NJ tree representing the concatenated sequences of the seven housekeeping gene fragments in 245 *mcr*-positive *E. coli* isolates of different ST types is shown in Figure [2](#F2){ref-type="fig"}. The phylogenetic analyses revealed that *E. coli* isolates harboring *mcr* genes were distributed in different lineages, and the isolated *E. coli* EC11 was located on a single branch rather than belonging to one of the ST10 branches.

![Neighbor-joining tree of 245 concatenated sequences of *E. coli* harboring *mcr-1* from multiple sources in different countries. The numbers at the nodes represent bootstrap values based on 500 replications. In bold and red underline presented the *E. coli* EC11isolate. ST, sequence type.](fmicb-09-02833-g002){#F2}

Genome Features of *E. coli* EC11 Harboring *mcr-1*
---------------------------------------------------

Whole gene sequencing (WGS) revealed that the serotype of the *E. coli* EC11 strain was H7. *E. coli* EC11 consisted of a chromosome and four circular plasmids (pEC11a, pEC11b, pEC11c, and pEC11d) (Table [2](#T2){ref-type="table"}). The chromosome genome size presented 4,933,784 bp, with a G+C content of 47.6%. With an exception of the *mcr-1*, unexpectedly, any other resistance genes were not defective in EC11. WGS results revealed the *mcr-1* gene, which showed 100% BLASTn identities to the known *mcr-1* gene of the reference plasmid pHNSHP45 of *E. coli* SHP45 ([@B17]). The *mcr-1* gene was only located on plasmid pEC11b, which was 31,229 bp in length and had an average G+C content of 41.40%, encoding 38 ORFs (Figure [3](#F3){ref-type="fig"}). Using PlasmidFinder, the plasmid pEC11b had a typical IncX4 plasmid backbone encoding replication, conjugation apparatus and stability functions, and was probably responsible for the movement of the plasmid between different bacterial hosts. The type II toxin--antitoxin module *hicA/hicB* was also identified in pEC11b. The putative virulence genes, such as *gad* (coding for glutamate decarboxylase), *lpf*A (long polar fimbriae) and *iss* (increased serum survival siderophore), were found in the chromosome of *E. coli* EC11.

###### 

General features of *E. coli* EC11 genomes.

  Replicons    Accession number   Size(bp)    MLST    Plasmid typing   Antibiotic resistance   GC (%)   ORF numbers   tRNA genes   rRNA genes
  ------------ ------------------ ----------- ------- ---------------- ----------------------- -------- ------------- ------------ ------------
  Chromosome   CP027255           4,933,784   ST278   --               --                      50.77    4,648         85           22
  pEC11a       CP027256           103,336     --      IncFIB           --                      48.08    119           0            0
  pEC11b       CP027257           31,229      --      IncX4            *mcr-1*                 41.74    38            0            0
  pEC11c       CP027258           31,467      --      --               --                      48.41    46            0            0
  pEC11d       CP027259           6,812       --      ColRNAI          --                      47.69    9             0            0

![Map of the *mcr-1*-containing plasmid pEC11b isolated. The *mcr-1* gene is marked in red. Figure was created with by the software SnapGene Viewer.](fmicb-09-02833-g003){#F3}

Genome Features of *mcr-1*-Carried Plasmid
------------------------------------------

BLASTn analysis showed that the backbone of the plasmid pEC11b (GenBank accession number [CP027257.1](CP027257.1)) was strikingly similar with (the query cover of 100% and the identities 99%) other previously sequenced *mcr-1-*carrying IncX4 plasmids, such as pICBEC72H of *E. coli* (isolated in Brazil; the GenBank accession no. CP015977.1), pMCR1-IncX4 of *Klebsiella pneumoniae* (China; KU761327.1), and pNG14043 of *Salmonella* (China; KY120364) (Figure [4](#F4){ref-type="fig"}). In all, these IncX4 plasmids bearing *mcr-1* showed very high architectural conservation.

![Linear comparison of complete plasmid sequences of plasmid pEC11b from *E. coli* EC11 (this study, accession no. CP027257), pICBEC72H from *E. coli* ICBEC72H (CP015977), pMCR1-IncX4 from *Klebsiella pneumoniae* SZ04 (KU761327) and pNG14043 from *Salmonella* NG14043 (KY120364). The arrows represent the position and transcriptional direction of the ORFs. Genes associated with the type IV secretion systems are indicated by blue arrows, resistance genes are indicated by red arrows, replication initiation protein are indicated pink, while accessory genes are indicated by jacinth arrows. Insertion sequences are highlighted in green arrows. The percentages of amino acid identity (above) and nucleic acid similarity (below) are shown between the homologous genes.](fmicb-09-02833-g004){#F4}

An approximately 2.6 kb *mcr-1-pap2* element was identified in the above-mentioned plasmids pEC11b, PICBEC72H, pMCR1-IncX4, and PNG14043. In addition, an IS*6* element was identified in pEC11b, IS*26* was identified in PICBEC72H and PNG14043, and *tnpA* was identified in pMCR1-IncX4 (Figure [4](#F4){ref-type="fig"}). The promoter sequences of *mcr-1* in all the aforementioned sequences were similar to that of pAf23 and pAf48 reported by Poirel et al ([@B25]) as well as pMCR1_IncI2 and BJ10 by Zhang et al ([@B43]) (Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}).

The putative conjugal transfer components of pEC11b were also detected by using *oriT*finder. A *tra* gene cluster encoding a T4SS belonging to Type P was predicted on pEC11b. It encoded a relaxase (*C6C13_26300*) belonging to the MOB~P~ family. It also encoded a T4CP (*C6C13_26225*) belonging to the VirD4 subfamily. The *oriT*-like region (coordinate: 27,146-27,223 bp) contained a pair of 14-bp IRs (GCAGGTGAGCAAAG...CTTTGTTCACCTGC). This evidence confirms that the plasmid pEC11b is a conjugative plasmid.

Discussion
==========

Colistin has been widely used as a veterinary drug for the treatment of enterobacterial infections and as an in-feed additive to promote healthy development in food-producing animals, especially in swine and poultry production ([@B11], [@B12]). Transfer of colistin resistance among bacteria in the gastrointestinal tract of livestock animals is a probable route for the dissemination of these bacteria ([@B8]; [@B10]). These routes can be via the food chain or direct human contact with animals as well as through contamination of fresh and seawater systems ([@B44]; [@B46]). In addition, the persistence of *mcr-1* in the human gastrointestinal tract microflora provides another route for dissemination of these bacteria ([@B5]). In this study, the *mcr-1-*carrying plasmid could be conjugated into *E. coli* C600 isolates *in vitro*. The *mcr-1* gene, if present in gut microbiota, can therefore be horizontally transmitted between different species in the microbiota.

Self-transmissible IncX4-type plasmids are now accepted as key vehicles responsible for the dissemination of the *mcr-1* gene among Enterobacteriaceae worldwide ([@B7]; [@B30]; [@B40]). In this study, we identified an IncX4-type plasmid carrying *mcr-1* in *E. coli* EC11, pEC11b, which was nearly identical to the other IncX4 plasmids bearing *mcr-1* in GenBank. IncX4 plasmid architecture is highly conserved and studies have shown similar IncX4 plasmids bearing *mcr-1* from different species. These species were isolated from different geographic locations and belonged to different STs ([@B30]; [@B40]). Plasmid pEC11b has four typical conjugal modules: an origin of transfer (*oriT*-like) region, a T4CP gene, a relaxase gene, and a gene cluster for the bacterial T4SS apparatus. The T4SS can act as a conjugative machine in conjugative plasmids ([@B3]). These gene clusters are vital to the HGT of intra- and inter-species bacterial resistance genes ([@B9]). Also, the plasmid pEC11b contains the *mcr-1*-*pap2* cassette which has proven that it could be horizontally transferred into diverse plasmid replicon types ([@B14]).

Multilocus sequence typing (MLST) is a powerful genetic fingerprinting technique for molecular epidemiology and population genetic studies of bacterial pathogens ([@B19]; [@B36]; [@B18]). In this study, we reported the first recorded instance of an *mcr-1* producing *E. coli* EC11 belonging to the ST278 lineage. We performed a MLST-based analysis of the *mcr*-positive *E. coli* population structure among 616 isolates collected in different laboratories in over 35 countries since 2016. The 245 STs among the 616 isolates indicate that the *mcr*-positive *E. coli* population is extremely diverse. Applying eBURST and NJ tree analyses simultaneously in this global dataset allows for better resolution in discerning the epidemiology and genetic population structure of *mcr*-positive isolates. Combined with previous studies ([@B20]), we speculate that the diversity in ST types of these *E. coli* strains may be related to highly promiscuous plasmids disseminating *mcr* genes. It also indicates that *mcr-1* has a huge risk of vertical transmission and may become more widespread and prevalent in the future. A ST which is highly disseminated in food, environment, animals, and human intestinal samples is ST10 ([@B20]; [@B31]). The epidemic clone ST131 ([@B23]), ST648 ([@B42]), and ST206 ([@B45]) were reported to be the most common STs associated with various β-lactamases, including ESBLs, NDM, and KPCs, etc. Many reports indicated that bacteria carrying *mcr-1* were often associated with ESBLs ([@B32]). In this study, *E. coli* EC11 only conferred resistance to polymyxin B, colistin, and trimethoprim-sulfamethoxazole, which are antibiotics that are extensively prescribed in veterinary medicine ([@B4]).

Currently, a number of countries have already restricted the use of colistin in animal production. China has now stopped the use of colistin as an antibiotic growth promoter ([@B38]). South Africa has responded to the threat of losing colistin as an antibiotic for human health through a program to advance national stewardship of colistin across the 'One Health' platform ([@B21]). The discovery of the *E. coli* strain EC11 with resistance to colistin in Shanghai emphasizes the importance of vigilance in detecting new threats like *mcr* genes to public health.

Conclusion
==========

In this work, we report the first case of colistin-resistant *mcr-1* gene in *E. coli* strain EC11 isolated from dairy cow feces in Shanghai, China. We show that this *E. coli* strain carrying the *mcr-1* gene can transfer resistance through HGT. This study confirms the need to monitor and survey the use of colistin and other types of antibiotics to enable proactive and effective strategies (e.g., risk assessment and risk management) for preserving the efficacy of antibiotics in the future.

Nucleotide Sequence Accession Number
------------------------------------

The genome sequences of the chromosome and four plasmids of the *E. coli* strain EC11 were deposited as GenBank accession no. [CP027255](CP027255)-[CP027259](CP027259).
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